The mechanism of action by which ocinaplon produces its anxiolytic effects is by modulating [[GABAA receptor|GABA<sub>A</sub>]] receptors,<ref>{{Cite journal|pmid=16339395|year=2006|author1=Mirza|first1=N. R.|title=Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination|journal=Journal of Pharmacology and Experimental Therapeutics|volume=316|issue=3|pages=1291–9|last2=Rodgers|first2=R. J.|last3=Mathiasen|first3=L. S.|doi=10.1124/jpet.105.094003}}</ref> although ocinaplon is more subtype-selective than most benzodiazepines.<ref>{{cite journal|pmid=15926867|year=2005|author1=Atack|first1=J. R.|title=The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics|journal=Expert Opinion on Investigational Drugs|volume=14|issue=5|pages=601–18|doi=10.1517/13543784.14.5.601}}</ref>
